Filter
6151
Filtered Results: 6151
Text search:
medical
products
Featured
Recommendations
675
New Publications
1593
Language
Document type
No document type
3147
Studies & Reports
1015
Guidelines
999
Manuals
412
Strategic & Response Plan
266
Training Material
112
Fact sheets
104
Situation Updates
54
Resource Platforms
14
Brochures
13
Infographics
10
Online Courses
4
App
1
Countries / Regions
Global
275
India
250
Kenya
183
Sierra Leone
131
South Africa
123
Nigeria
119
Western and Central Europe
116
Liberia
111
Ethiopia
107
Nepal
97
Uganda
95
Latin America and the Carribbean
88
Ghana
83
Rwanda
82
Malawi
82
Tanzania
82
Africa
78
Zambia
74
Ukraine
73
Myanmar / Burma
73
Bangladesh
72
Syria
65
Namibia
58
Philippines
57
South–East Asia Region
48
Guinea
41
Congo, Democratic Republic of
41
Zimbabwe
40
West and Central Africa
39
Eastern Europe
37
East and Southern Africa
35
Lesotho
33
Cambodia
33
Asia
32
Haiti
31
Mozambique
29
Indonesia
28
Eastern Europe and Central Asia
27
Senegal
26
Middle East and North Africa
25
Burkina Faso
23
Russia
23
Eswatini/ Swaziland
23
South Sudan
22
Venezuela
19
Pakistan
19
Botswana
18
Germany
17
Brazil
17
Cameroon
16
Yemen
16
Moldova
14
Jordan
13
Western Pacific Region
13
Vietnam
13
Sudan
12
Benin
11
Afghanistan
11
USA
11
Colombia
10
Thailand
10
China
10
Mali
10
Tajikistan
9
Lebanon
9
Côte d’Ivoire / Ivory Coast
8
Georgia
8
Central African Republic
8
Somalia
8
Madagascar
8
North Macedonia
7
Albania
7
Turkey
6
Iran
6
Laos
6
North America
6
Iraq
6
Kazakhstan
5
Peru
5
Poland
5
Serbia
4
Kyrgyzstan
4
Saudi Arabia
4
Paraguay
4
United Kingdom
4
Argentina
4
Sri Lanka
4
Egypt
4
Romania
4
Palestine
4
Chad
4
Timor Leste/ East Timor
3
Fiji
3
Uzbekistan
3
Japan
3
Mauritius
3
Southern Africa
3
Bolivia
3
Papua New Guinea
3
Angola
3
Bhutan
3
Ecuador
3
Guatemala
3
Switzerland
2
Gambia
2
Chile
2
Singapore
2
Estonia
2
Burundi
2
Malaysia
2
Mongolia
2
Qatar
2
Bulgaria
2
Armenia
2
Guinea-Bissau
2
Croatia
2
Hungary
2
Turkmenistan
2
Jamaica
2
Spain
2
Slovakia
2
Honduras
2
Libya
2
El Salvador
1
Australia
1
Togo
1
Canada
1
Congo-Brazzaville
1
Niger
1
Morocco
1
Mauritania
1
Italy
1
Dominican Republic
1
Ireland
1
Gabon
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Morocco
1
Belarus
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Djibouti
1
Greece
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2179
Clinical Guidelines
571
Public Health
380
Women & Child Health
367
Key Resources
365
Capacity Building
108
Pharmacy & Technologies
104
Annual Report MEDBOX
1
Toolboxes
COVID-19
543
HIV
404
Mental Health
385
TB
286
AMR
222
NTDs
208
Pharmacy
206
Disability
203
Ebola & Marburg
191
Caregiver
181
Planetary Health
179
Conflict
166
Rapid Response
138
NCDs
121
Global Health Education
98
Refugee
87
Malaria
85
2.0 Rapid Response
84
Health Financing Toolbox
68
Natural Hazards
66
Specific Hazards
59
Cholera
45
Zika
43
Polio
27
Social Ethics
15
Typhoon
3
This guidance note on Syria is the first in a series of comprehensive Q&As, which aims to give practical guidance on how to comply with EU sanctions when providing humanitarian aid, in particular medical assistance, to fight the coronavirus pandemic. By clarifying the responsibilities and processes ...
A discussion paper outlining the first steps in developing a nutrient profile model to drive changes to product composition and labelling and promotion practices in the WHO European Region
The aims of the guidance are to protect breastfeeding, prevent obesity and chronic diseases, promote a healthy...
Manual for use in primary care.
There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural relevance for substances other than alcohol or tobacco,...
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this inclu...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis.
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Health communication has proven to play a crucial role in addressing diseases such as dengue, Zika and chikungunya, for which there are no definitive or easily accessible vaccines. In this context, this discipline becomes a fundamental tool to promote the change behavior and promote preventive pract...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
Humanitarian emergencies and crises (Humanitarian emergencies and crises) are large-scale events that may result in the breakdown of health care systems and society, forced displacement, death, and physical, psychological, social and spiritual suffering on a massive scale. Current responses to Human...
This document is intended for a wide audience including national and local policymakers, implementers and managers of national and local maternal and child health programmes, non-governmental and other organizations and professional societies involved in the planning and management of maternal and c...
Management of a cholera epidemic
recommended
Practical guide for doctors, nurses,laboratory technicians, medical auxiliaries,water and sanitation specialists and logisticians.
The document is a comprehensive guide for managing cholera epidemics, providing detailed protocols for prevention, outbreak investigation, treatment, and control mea...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
WHO has developed a new health kit to support treatment for chronic disease patients in emergency settings. The prevalence of NCDs is increasing worldwide, including in emergency/crisis-prone areas. Yet current humanitarian response has not accounted for this emerging burden. The NCD kit attends to ...
